GioTag, the 1st global study to show feasibility of sequential therapy with GIOTRIF® followed by osimertinib
12/04/2024 | Author: Boehringer Ingelheim
Document ID: PC-MY-102819
12/04/2024 | Author: Boehringer Ingelheim
Document ID: PC-MY-102819